Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings - Entero Therapeutics ( NASDAQ:ENTO )
BOCA RATON, Fla., Sept. 10, 2024 ( GLOBE NEWSWIRE ) -- Entero Therapeutics, Inc., ENTO, ( "Entero Therapeutics" or the "Company" ) , a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ( GI ) diseases, today ...
| Ticker |
Sentiment |
Impact |
|
ENTO
|
Somewhat Bullish
|
53 %
|
|
MDT
|
Neutral
|
3 %
|
|
WISA
|
Somewhat Bullish
|
5 %
|
